Five markets that don’t need the battery to work.

Battery grade is also pharma grade, food grade, and drinking-water grade.

The Track-B skid (dissolve, reject, polish, recrystallize, QA, all under DeltaV recipe control) makes battery-grade MgCl₂/CaCl₂. But battery grade is also pharma grade, food grade, and drinking-water remineralization grade. That last one is a global-health product: billions of people drink demineralized or desalinated water that must be re-mineralized with high-purity Mg/Ca to be healthy. Nedmag already sells into exactly this market.

If the battery never scales, Emerson still owns an automated, documented, licensable high-purity-salt purification skid, and a reason to be proud of it. Every DeltaV recipe is a repeatable process the sales organization can price as a unit.

The copper rescue, repeated: every impurity is a candidate product.

Phase 1 already turns a maintenance step into revenue: dissolved copper from the cathode is electrowon back into ~99.5% dendritic powder and sold (~$13/kg). That is a pattern. Every element the purification is forced to remove is a candidate product:

• Copper: recovered today via electrowinning. Proven.
• Boron: must be removed anyway as a battery impurity; recover it as boric acid / borates instead of discarding. Pure margin on a required step.
• Lithium: the prize. Potash and desal brines carry lithium at $9,000–17,000/ton. Our own cathode material is no help here (copper hexacyanoferrate is Cs⁺/K⁺/NH₄⁺-selective and puts Li⁺ last, per the selectivity sequence); the lithium-selective sorbents are Mn/Ti spinels and Al-hydroxide LDH, a bolt-on direct-lithium-extraction stage on the same skid. If the feedstock brines assay meaningful lithium, this stream can rival the battery itself.
• Potassium (as potash KCl): a fertilizer product with Intrepid as the built-in buyer. The monovalent reject splits into potash sold + NaCl reused as the ion-exchange regenerant.
• Ba / Sr: captured as insoluble sulfate solids (barite / celestine), gradeable to API drilling-mud spec or specialty markets.
• Bromide (as NaBr salt): sold as the benign salt for high-density clear-brine drilling fluids or as feedstock to bromine producers who already own the elemental-Br₂ infrastructure.

The frame: brine in; copper, boron, lithium, potash, barite, and Mg/Ca out. Purification stops being a cost and becomes a poly-mineral recovery platform.

Byproduct handling & offtake: each is an established commodity with a known form, hazard class, and buyer.

Recovery only counts if each product can be safely stored, shipped, and sold. The reassuring answer: almost every recovered stream is an established commodity chemical with mature, well-understood handling (non-hazmat or mild), with one specific flag (fine copper powder, NFPA 484 combustible-dust practice). Full portfolio is assay-driven: a feedstock ICP + halide panel confirms which streams are present at recoverable grade.

Turn a pollution stream into mineral products.

Desal plants discharge hypersaline reject brine that damages coastal ecosystems, a growing environmental crisis with no clean answer. The same recovery plant that pulls Mg/Ca (and Cu/B/Li) from that brine also remediates it. This is a good-for-the-world business independent of any battery: turn a pollution stream into mineral products. It may end up larger than the cell.

Huntington Beach, Poseidon Water’s next California build, died in 2022 partly over brine discharge. A Carlsbad plant that turns reject brine into minerals at scale changes that conversation for every desal proposal after it. The Carlsbad Play lays out the full staged capex + political stack; here, note only that the remediation business stands whether or not the battery scales, and that Emerson is the automation vendor for that entire market either way.

A capability that pays off regardless of which chemistry wins the market.

The DeltaV / AspenTech / ICP-gated QA methodology for battery-grade materials applies to every battery chemistry: LFP, sodium-ion, whatever the market picks. Emerson can sell “automated battery-materials QA and process control” to the entire industry regardless of which cell wins. The pilot lab becomes a permanent battery-materials capability.

This is the one that de-risks Emerson against the entire question “what if lithium or sodium wins.” The methodology, the recipe library, the impurity-tolerance dataset, and the ELN/LIMS traceability travel to any battery buyer who needs QA at grid-BESS scale. It is the pick-axes-to-every-miner play, applied to battery materials rather than the batteries themselves.

A hard-won sales proof-point into mining, potash, and desalination.

Rosemount and Micro Motion instruments validated in concentrated, corrosive, high-density chloride brine is a sales proof-point into markets Emerson already serves but where brine-duty validation is scarce: mining, potash, and desalination. The pilot generates that data as a byproduct of running. Every DeltaV historian log becomes a citation the sales organization can use.

Emerson can afford to be generous with the chemistry, because the money is in the picks.

The IP posture that fits Emerson’s actual business model: defensive and enabling patents, never blocking or rent-extraction. File to guarantee the right to deploy and to stop a troll from fencing off a climate solution.

• Patent to secure freedom. Defensive publication (publish to create prior art) for anything Emerson doesn’t need to own is itself a humanitarian tool; it keeps the commons open.
• A patent pledge, Tesla-style. Publicly covenant not to enforce against good-faith grid-storage deployment. Tesla did this in 2014 (“all our patents belong to you”) and it accelerated EV adoption while Tesla still won. A pledge is both the ethical act and the growth lever.
• License generously, profit on the picks. Emerson’s margin sits in the DeltaV / Rosemount / purification-skid / Plantweb stack every deployment needs. Low-cost / open licensing of the chemistry grows the market for Emerson’s picks. The humanitarian choice and the commercial choice point the same direction.
• Three filings keep the data-moat defensible without extracting rent: the impurity dose-response QA spec (thresholds per ion, from the contamination rig, as a method claim plus trade secret), the dual-mode BMS estimator (window control across the Mg:Ca range), and the Br/Cl management scheme if the rig finds one. The mixed Mg/Ca composition and the two-electron CuHCF cathode are freedom-to-operate questions, published defensively rather than filed, matching the proposal’s IP line. Spec + estimator + scheme is defense in depth; none of the three is a blocker on good-faith deployment.

Why this strengthens the Emerson pitch: “We are securing the freedom to deploy a climate solution at scale and selling the automation every deployment requires” is a far stronger internal-R&D narrative than a defensive-moat story, and it is true to Emerson’s actual business model.

What Emerson owns at the end is a capability.

Fund the pilot and, best case, you help launch a new battery category. Worst case, you still own five sellable capabilities and you have made drinking water safer and desal brine cleaner along the way. That is a floor most R&D bets do not have.

The If the Battery Fails page walks the gate-by-gate resilience map that turns this portfolio into an explicit business case, showing exactly what survives each way the pilot can go sideways, and why $1.8M is an option.

The science is not finished when Phase 1 reports; the proposal’s Where the Telescope Tilts Next lists the six measurements this same instrument stack and its partner labs can settle after it, each with its phase, its worth, and its evidence tag.